ARWR Stock Analysis: Buy, Sell, or Hold?
ARWR - Arrowhead Research Corporation
$59.82
-3.78 (-5.94%)
▼
5d:
-5.45%
30d:
-12.11%
90d:
-6.0%
HOLD
MODERATE Confidence
Analysis Updated: Mar 6, 2026 12:00 AM ET
Earnings: Feb 10, 2026
0d
Smart Money Accumulation
ARWR is down 9.6% this week, but smart money is accumulating calls. Top strike: $65 2026-03-20 with 2,158 OI. Call ratio: 88% View Scanner →
Strength: 8.6/10
Get Alerted When ARWR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ARWR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ARWR shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ARWR is currently trading at $59.82, which is considered oversold relative to its 30-day fair value range of $61.90 to $67.83.
Technical Outlook: Technically, ARWR is in a strong uptrend. The price is currently testing key support at $58.72. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.9% recently.
Market Sentiment: ARWR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $81.36 (+36.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARWR is in a strong uptrend. The price is currently testing key support at $58.72. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.9% recently.
Market Sentiment: ARWR has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $81.36 (+36.0%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$61.90 -
$67.83
Company Quality Score
41/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
Protect Your Profits
Holding ARWR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.9%)
- BULLISH: Trading 36.0% below Wall St target ($81.36)
- CAUTION: 5-day price weakness (-5.5%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$61.90 -
$67.83
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$58.72
Resistance Level
$67.15
Current Trend
Strong Uptrend
Technical data as of
Mar 6, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-13.92
Wall Street Target
$81.36
(+36.0%)
Revenue Growth (YoY)
10461.3%
Earnings Growth (YoY)
9.8%
Profit Margin
18.5%
Share & Embed Analysis
Last updated: March 06, 2026 6:10 PM ET
Data refreshes hourly during market hours. Next update: 7:10 PM
Data refreshes hourly during market hours. Next update: 7:10 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARWR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
17
Sells
Net
INSIDERS SELLING
Recent Transactions
Patrick O'brien
SELL
49493 shares
2026-01-05
James C Hamilton
SELL
40164 shares
2026-01-05
Christopher Richard Anza…
SELL
13187 shares
2026-01-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$63 | 55 HOLD |
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 45 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1028 | 48 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$213 | 53 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
Advanced ARWR Option Strategies
Professional options setups generated by AI based on today's ARWR price and gamma walls.
